<DOC>
	<DOCNO>NCT00002076</DOCNO>
	<brief_summary>To evaluate safety effectiveness fluconazole treatment acute cryptococcal meningitis AIDS patient . Both newly diagnose relapsed patient eligible .</brief_summary>
	<brief_title>Pilot Study Oral Fluconazole Treatment Acute Cryptococcal Meningitis</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningitis , Cryptococcal</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Antiviral therapy zidovudine . Prophylaxis Pneumocystis carinii pneumonia . Aerosolized pentamidine . Concurrent Treatment : Allowed : Radiation therapy mucocutaneous Kaposi 's sarcoma . Written informed consent must obtain patient , either patient patient 's legal guardian . No prior systemic antifungal therapy cryptococcosis . Success prior therapy must document negative cerebrospinal fluid ( CSF ) culture end therapy . Following prior therapy , patient may receive 1 mg/kg/wk amphotericin B 4 week entry study . Prior Medication : Allowed : Antiviral therapy zidovudine . Prophylaxis Pneumocystis carinii pneumonia . Aerosolized pentamidine . Exclusion Criteria Coexisting Condition : Patients follow exclude : Evidence acute chronic meningitis base upon etiology cryptococcosis . History allergy intolerance imidazole , azoles , amphotericin B . Moderate severe liver disease define specify lab value . Patients unable take oral medication . Unlikely survive 2 week . Renal impairment . Concurrent Medication : Excluded : Coumarintype anticoagulant . Oral hypoglycemics . Barbiturates . Phenytoin . Immunostimulants . Investigational drug approve ( license ) drug investigational indication aerosolize pentamidine . Excluded within 4 week study entry : Greater 1 mg/kg/wk amphotericin B . Any exception prohibition concomitant medication must approve Pfizer Central Research . Concurrent Treatment : Excluded : Lymphocyte replacement . Patients follow exclude : Evidence acute chronic meningitis base upon etiology cryptococcosis . History allergy intolerance imidazole azoles . Moderate severe liver disease define specify lab value . Patients unable take oral medication . Life expectancy &lt; 2 week . Any condition may impair absorption oral medication . Prior Medication : Excluded : Coumarintype anticoagulant . Oral hypoglycemics . Barbiturates . Phenytoin . Immunostimulants . Investigational drug approve ( license ) drug investigational indication aerosolize pentamidine . Excluded within 4 week study entry : Greater 1 mg/kg/wk amphotericin B . Prior Treatment : Excluded : Lymphocyte replacement .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 1990</verification_date>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Meningitis</keyword>
	<keyword>Cryptococcosis</keyword>
	<keyword>Fluconazole</keyword>
	<keyword>Administration , Oral</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
</DOC>